BR100 Increased By (0.03%)
BR30 Decreased By (-0.04%)
KSE100 Increased By (0.07%)
KSE30 Increased By (0.08%)
AGHA 6.62 Decreased By ▼ -0.05 (-0.75%)
BECO 4.38 Increased By ▲ 0.03 (0.69%)
BML 56.17 Decreased By ▼ -1.15 (-2.01%)
BOP 30.10 Decreased By ▼ -0.02 (-0.07%)
CNERGY 12.93 Decreased By ▼ -0.05 (-0.39%)
CSIL 5.32 Increased By ▲ 0.01 (0.19%)
FCCL 51.90 Increased By ▲ 0.25 (0.48%)
FFL 14.50 Increased By ▲ 0.01 (0.07%)
FNEL 1.23 Increased By ▲ 0.02 (1.65%)
KEL 6.08 Increased By ▲ 0.02 (0.33%)
KOSM 5.86 Increased By ▲ 0.02 (0.34%)
LOTCHEM 26.15 Decreased By ▼ -0.02 (-0.08%)
MLCF 91.35 Increased By ▲ 0.12 (0.13%)
NBP 163.90 Decreased By ▼ -0.29 (-0.18%)
NCPL 53.20 Increased By ▲ 0.02 (0.04%)
NPL 59.25 Increased By ▲ 0.13 (0.22%)
OGDC 313.00 Decreased By ▼ -0.39 (-0.12%)
PACE 9.71 Decreased By ▼ -0.06 (-0.61%)
PAEL 35.49 Increased By ▲ 0.25 (0.71%)
PIBTL 14.76 Increased By ▲ 0.05 (0.34%)
PPL 220.60 Decreased By ▼ -0.76 (-0.34%)
PRL 91.80 Increased By ▲ 0.58 (0.64%)
PTC 59.65 Increased By ▲ 0.46 (0.78%)
SSGC 23.37 Increased By ▲ 0.07 (0.3%)
TBL 8.83 Increased By ▲ 0.08 (0.91%)
TELE 7.65 Increased By ▲ 0.04 (0.53%)
TPL 22.03 Decreased By ▼ -0.32 (-1.43%)
TPLP 12.70 Increased By ▲ 0.14 (1.11%)
TREET 21.77 Increased By ▲ 0.04 (0.18%)
TRG 55.90 Increased By ▲ 0.11 (0.2%)
By

The World Health Organization on Thursday issued an emergency use listing for the single-dose COVID-19 vaccine from China-based CanSino Biologics.

The vaccine, Convidecia, is the eleventh shot against the coronavirus to get clearance from the global health agency, whose advisory group recommended its use in people of age 18 years and above.

AstraZeneca bolsters COVID therapeutics with RQ Bio deal

The vaccine was found to have 64% efficacy against symptomatic disease and 92% against severe COVID-19, the agency said.

Other vaccines that have similar clearance from the agency include those made by Pfizer Inc and BioNTech, Moderna Inc, AstraZeneca Plc, Johnson & Johnson and Novavax Inc.

Comments

Comments are closed for this article.